AbCellera Biologics Inc. ABCL Finite Lived Intangible Assets - Gross
Finite Lived Intangible Assets - Gross at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s finite lived intangible assets - gross.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s finite lived intangible assets - gross?
- AbCellera Biologics Inc. (ABCL) reported finite lived intangible assets - gross of $69.32M in Q1 2026.
- How has AbCellera Biologics Inc.'s finite lived intangible assets - gross changed year-over-year?
- AbCellera Biologics Inc.'s finite lived intangible assets - gross decreased by 23.9% year-over-year, from $91.13M to $69.32M.
- What is the long-term trend for AbCellera Biologics Inc.'s finite lived intangible assets - gross?
- Over 2 years (2023 to 2025), AbCellera Biologics Inc.'s finite lived intangible assets - gross has grown at a -33.2% compound annual growth rate (CAGR), from $155.14M to $69.32M.
- What does finite lived intangible assets - gross mean?
- This metric tracks the total historical cost of intangible assets that have a defined useful life, such as patents, software licenses, or customer relationships. It excludes assets with indefinite lives like certain trademarks or goodwill. It is a key indicator of the company's investment in intellectual property and intangible competitive advantages.